Lipid Regulators Market Size & Share 2024 to 2032
Market Size by Type (Statins [Branded, Combination], Non-statins [Fibric-acid Derivatives, Bile-acid]), by Indication (Hypercholesterolemia, Coronary Artery Disease), by Route of Administration, Distribution Channel & Forecast.
Report ID: GMI8442
|
Published Date: March 2024
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Lipid Regulators Market Size
Lipid Regulators Market was valued at USD 32.4 billion in 2023 and is set to register a CAGR of 3.8% from 2024 – 2032. The lipid regulators industry is experiencing growth driven by factors such as the rising prevalence of dyslipidemia and cardiovascular disease, advancements in drug development, increased prescription rate, and growing awareness of the importance of lipid management in reducing cardiovascular risk. Also, with the growing ageing population and increasing focus on preventive healthcare, the market is expected witness lucrative growth over the coming years.
Lipid Regulators Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
For instance, according to World Population Prospects 2022, the population aged 65 years and above is expected to rise from 10% in 2022 to 16% in 2050. As the population ages, the risk of developing dyslipidemia and cardiovascular disease also increases, thereby driving the growth of the market.
Lipid regulators, also known as lipid-lowering agents or lipid-lowering drugs, are medications used to manage abnormal levels of lipids (fats) in the blood, primarily cholesterol and triglycerides. Elevated levels of these lipids are associated with an increased risk of cardiovascular diseases such as heart attacks and strokes. Lipid regulators can help lower cholesterol and triglyceride levels, reducing the risk of these diseases.
Lipid Regulators Market Trends
Lipid Regulators Market Analysis
The global market based on type is segmented into statins and non-statins. The statins segment dominated the global market in 2023 with 60.1% market share and is anticipated to grow at CAGR of 4.1% during the analysis period.
The market based on indication is categorized into hypercholesterolemia, hypertriglyceridemia, coronary artery disease, and other indications. The hypercholesterolemia segment accounted for highest market share and was valued at USD 13.1 billion in 2023.
The market based on route of administration is classified into oral and injectable. The oral segment held highest market share in 2023 and is anticipated to be valued at USD 37.3 billion by 2032.
Global market based on distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held majority of market share and is projected to grow at 3.7% CAGR from 2024 – 2032.
North America lipid regulators market accounted for USD 13.6 billion revenue in 2023 and is projected to reach USD 18.1 billion by 2032.
Lipid Regulators Market Share
The lipid regulators industry is dynamic and multifaceted, characterized by several key players and a diverse range of lipid regulators. Competition in the global market is influenced by factors such as drug efficacy, safety, pricing, marketing strategies, and regulatory approvals. Companies strive to differentiate their products through clinical advancements, novel mechanisms of action, and strategic partnerships to gain market share and maintain a competitive edge in this dynamic and rapidly evolving market.
Lipid Regulators Market Companies
Prominent players operating in the lipid regulators industry include:
Lipid Regulators Industry News:
The lipid regulators market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Indication
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →